Prohibition Partners LIVE - Day One Preview: Science, Research & Technology
OVER the next three days, Prohibition Partners LIVE features a packed programme of discussion and debate featuring some of the global cannabis industry’s most informed leaders and opinion-makers.
The focus for Day One is Science, Research & Technology, beginning at midday BST with pre-event networking sessions, followed by an opening address from Prohibition Partners Co-Founder, Stephen Murphy.
First up on the Cannabis Europa platform at 13:30 BST will be an overview of the rapidly growing industrial hemp industry entitled; Building a Hempire: Hemp & the Potential Impact on Global Markets.
This features Lorenza Romanese, Managing Director of European Industrial Hemp Association, Jamie Bartley, CEO of Unyte Hemp, and is hosted by Michael Schaeffer Omer-Man, Senior Cannabis Editor at The Cannigma.
Hemp is blazing a trail through a host of industries including textiles, agriculture and construction as it becomes the go-to crop for the emerging green industrial revolution.
Second up on the Cannabis Europa stage will be a well-informed panel discussing the issues surrounding medical cannabis prescription in the UK entitled: Is There a Doctor in the House? Patient Access to Medical Cannabis.
This will be hosted by Richard Hurley, Features and Debates Editor at The British Medical Journal with Professor Mike Barnes, Chair of the Medical Cannabis Clinicians Society, Dr Rebecca Moore Consultant Psychiatrist, also at The Medical Cannabis Clinics and Bradley Moore CEO & Director Global Cannabis Applications Corp. With so few prescriptions being generated by NHS clinicians, what can be done to help break this impasse?
Following a break, and starting at 15:15 BST, the first of two discussions on Day One on the potential efficacy of emerging cannabinoids entitled: New and Minor Cannabinoids: What Are They and How Can They be Used to Treat Patients?
This will feature Dr. Anne Katrin Schlag, Head of Research at Drug Science, Dr. Peter Blecher, Chief Medical Officer at WeedMD, Lex Wolfe Working Group Member at the Patient-Led Engagement for Access, and Professor Roger Pertwee, Emeritus Professor at the University of Aberdeen in Scotland. This will also be followed by a live Q&A* with an opportunity to hear more directly from our panel of experts (*Live Q&A is exclusively available to Networking and VIP Pass holders).
Cannabis Americana begins at 16:00 BST and starts by examining how cannabis can help individuals support their own mental and physical health.
Entitled: Where Wellness and Cannabis Collide: A Look to the Future Across Yoga, Meditation, Beauty and Beyond it features Jessamyn Stanley, Chief Executive Officer of JOS, Inc, Dr Amanda Reiman, VP of Community Development, Flow Cannabis Company, and will be hosted by Elana Goldberg, CEO of The Cannigma.
The second visit to the subject of the minor cannabinoids is up next at 17:15 BST and is entitled; New and Minor Cannabinoids: What Does the Future Hold?
With the rise in popularity of both CBG and Delta 8 in regions such as the USA, and even the recent emergence of Delta 9, we take a look at what the immediate future looks like for new and alternative cannabinoids in the US market.
This will be hosted by Mona Zhang, a Senior Reporter at Politico, and features Dr Peter Grinspoon, MD, Instructor, Harvard Medical School and Jonathan Miller, General Counsel of the US Hemp Roundtable.
At 18:00 BST is our next session - Blockchain in Cannabis - which will examine how innovative businesses are using Crypto and Blockchain technologies to add not only value, but to increase accountability to their supply chain
It will be hosted by Oisin Lunny, a TedX Speaker & SXSW Board Advisor and feature Robert Galarza, Chief Executive Officer, TruTrace Technologies, Inc and Chris Naprawa, President Taal Distributed Information Technologies Inc.
Our featured presentation From Pain to Strain: Using Machine Learning for Efficacy - Masterclass is with Bradley Moore CEO & Director of Global Cannabis Applications Corp (GCAC) and starts at 18:45 BST.
With over 20 years of business leadership from start-ups to Fortune 500 companies, Brad entered the medical cannabis industry in 2017, with a vision of using advanced technologies to create a better outcome for medical cannabis patients.
In the Medical Cannabis ecosystem, one of the primary pain points for cultivators and consumers alike is compliance, authentication, tracking, and certification of products to ensure quality, consistency, and, most importantly, efficacy.
In his Masterclass, Brad will discuss how GCAC’s Citizen Green Efixii harnesses the first-of-its-kind end-to-end solution, based on multiple interlocking technologies such as mobile applications, artificial intelligence, smart databases and an Ethereum blockchain.
Following Brad’s presentation there will be an opportunity join some of our speakers, partners and fellow VIP's from day one of Prohibition Partners LIVE. Afford the opportunity to introduce yourself to the industry, ask questions, spark a debate and find new ways to achieve your goals. It runs between 19:15 and 20:30 BST.